Introduction

Dr James Thompson is an experienced robotic, laparoscopic, endoscopic and open urological surgeon, having completed a 6-year College of Surgeons accredited training program in all aspects of general urology in 2016.

He has specialty training in (and passion for) the treatment of prostate and bladder cancer using the latest robotic surgery techniques. He undertook a post-graduate fellowship in robotic and open uro-oncology at University College London Hospital in 2017, then was appointed at UCLH as a consultant robotic and open uro-oncologic surgeon in late 2017.

In 2018, he accepted an offer to return to Sydney as a staff specialist at St George Hospital and to join the team at The Urology Practice striving for excellence in urologic care.

Qualifications

• BSc(Med) MBBS (Hons 1^st Class), University of NSW (2007)
• FRACS (Urology), Royal Australasian College of Surgeons/ Urological Society of ANZ (2016)
• PhD (Prostate Cancer Research), University of NSW (2017)
• IMGSS Robotic Oncology Fellowship, Royal College of Surgeons (Ed), UCLH (2017)

Clinical Appointments

Dr Thompson has admitting rights at the following hospitals:

• St George Public Hospital (Staff Specialist)
• Hurstville Private Hospital
• St George Private Hospital, Kogarah
• St Vincents Private Hospital, Darlinghurst

Academic Appointments

• Conjoint Senior Lecturer, Faculty of Medicine UNSW
• Senior Research Fellow, Kinghorn Cancer Centre/ Garvan Institute of Medical Research

Active member of the following professional groups

• RACS – Royal Australasian College of Surgeons
• USANZ – Urological Society of ANZ
• ANZUP – Australian & New Zealand Urogenital/ Prostate Cancer Trial Group
• EAU – European Association of Urology
• ERUS – EAU Robotic Urology Section
• AUA – American Urological Association
• BAUS – British Association of Urological Surgeons
• GMC – General Medical Council, UK

Research & Publications

Dr Thompson has co-authored over 30 original research publications in addition to book chapters and invited lectures in the field of urologic cancer. He is a regular reviewer for high-impact journals such as European Urology, Lancet Oncology and the Journal of Urology. He is a co-investigator on several ongoing research projects in the fields of MRI, PSMA, Combidex ferromagnetic MRI, active surveillance, focal therapy (including HIFU & nanoknife), robotic surgery, epigenetics & radiogenomics.